Literature DB >> 24227776

Epithelial NF-κB orchestrates house dust mite-induced airway inflammation, hyperresponsiveness, and fibrotic remodeling.

Jane E Tully1, Sidra M Hoffman, Karolyn G Lahue, James D Nolin, Vikas Anathy, Lennart K A Lundblad, Nirav Daphtary, Minara Aliyeva, Kendall E Black, Anne E Dixon, Matthew E Poynter, Charles G Irvin, Yvonne M W Janssen-Heininger.   

Abstract

NF-κB activation within the epithelium has been implicated in the pathogenesis of asthma, yet the exact role of epithelial NF-κB in allergen-induced inflammation and airway remodeling remains unclear. In the current study, we used an intranasal house dust mite (HDM) extract exposure regimen time course in BALB/c mice to evaluate inflammation, NF-κB activation, airway hyperresponsiveness (AHR), and airway remodeling. We used CC10-IκBαSR transgenic mice to evaluate the functional importance of epithelial NF-κB in response to HDM. After a single exposure of HDM, mRNA expression of proinflammatory mediators was significantly elevated in lung tissue of wild-type (WT) mice, in association with increases in nuclear RelA and RelB, components of the classical and alternative NF-κB pathway, respectively, in the bronchiolar epithelium. In contrast, CC10-IκBαSR mice displayed marked decreases in nuclear RelA and RelB and mRNA expression of proinflammatory mediators compared with WT mice. After 15 challenges with HDM, WT mice exhibited increases in inflammation, AHR, mucus metaplasia, and peribronchiolar fibrosis. CC10-IκBαSR transgenic mice displayed marked decreases in neutrophilic infiltration, tissue damping, and elastance parameters, in association will less peribronchiolar fibrosis and decreases in nuclear RelB in lung tissue. However, central airway resistance and mucus metaplasia remained elevated in CC10-IκBαSR transgenic mice, in association with the continued presence of lymphocytes, and partial decreases in eosinophils and IL-13. The current study demonstrates that following airway exposure with an asthma-relevant allergen, activation of classical and alternative NF-κB pathways occurs within the airway epithelium and may coordinately contribute to allergic inflammation, AHR, and fibrotic airway remodeling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24227776      PMCID: PMC3858534          DOI: 10.4049/jimmunol.1301329

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

Authors:  U Senftleben; Y Cao; G Xiao; F R Greten; G Krähn; G Bonizzi; Y Chen; Y Hu; A Fong; S C Sun; M Karin
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

Review 2.  Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.

Authors:  Gutian Xiao; Arnold B Rabson; Wise Young; Guoliang Qing; Zhaoxia Qu
Journal:  Cytokine Growth Factor Rev       Date:  2006-06-21       Impact factor: 7.638

3.  CXC chemokines modulate IgE secretion and pulmonary inflammation in a model of allergic asthma.

Authors:  Laura McKinley; Jiyoun Kim; Gerald L Bolgos; Javed Siddiqui; Daniel G Remick
Journal:  Cytokine       Date:  2005-11-14       Impact factor: 3.861

Review 4.  Growth and differentiation of conducting airway epithelial cells in culture.

Authors:  R Wu; Y H Zhao; M M Chang
Journal:  Eur Respir J       Date:  1997-10       Impact factor: 16.671

Review 5.  Airway wall liquid. Sources and role as an amplifier of bronchoconstriction.

Authors:  D Yager; R D Kamm; J M Drazen
Journal:  Chest       Date:  1995-03       Impact factor: 9.410

6.  Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness.

Authors:  Rhonda H Wilson; Gregory S Whitehead; Hideki Nakano; Meghan E Free; Jay K Kolls; Donald N Cook
Journal:  Am J Respir Crit Care Med       Date:  2009-08-06       Impact factor: 21.405

7.  Cooperation between classical and alternative NF-κB pathways regulates proinflammatory responses in epithelial cells.

Authors:  Jane E Tully; James D Nolin; Amy S Guala; Sidra M Hoffman; Elle C Roberson; Karolyn G Lahue; Jos van der Velden; Vikas Anathy; Timothy S Blackwell; Yvonne M W Janssen-Heininger
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-31       Impact factor: 6.914

8.  Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9.

Authors:  Laurie Whittaker; Naiqian Niu; U-Angela Temann; Amy Stoddard; Richard A Flavell; Anuradha Ray; Robert J Homer; Lauren Cohn
Journal:  Am J Respir Cell Mol Biol       Date:  2002-11       Impact factor: 6.914

9.  A prominent role for airway epithelial NF-kappa B activation in lipopolysaccharide-induced airway inflammation.

Authors:  Matthew E Poynter; Charles G Irvin; Yvonne M W Janssen-Heininger
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

10.  Nuclear factor-kappaB activation in airway epithelium induces inflammation and hyperresponsiveness.

Authors:  Cristen Pantano; Jennifer L Ather; John F Alcorn; Matthew E Poynter; Amy L Brown; Amy S Guala; Stacie L Beuschel; Gilman B Allen; Laurie A Whittaker; Mieke Bevelander; Charles G Irvin; Yvonne M W Janssen-Heininger
Journal:  Am J Respir Crit Care Med       Date:  2008-02-08       Impact factor: 21.405

View more
  42 in total

1.  Mitochondrial CaMKII inhibition in airway epithelium protects against allergic asthma.

Authors:  Sara C Sebag; Olha M Koval; John D Paschke; Christopher J Winters; Omar A Jaffer; Ryszard Dworski; Fayyaz S Sutterwala; Mark E Anderson; Isabella M Grumbach
Journal:  JCI Insight       Date:  2017-02-09

2.  CARMA3 Is Critical for the Initiation of Allergic Airway Inflammation.

Authors:  Benjamin Causton; Ravisankar A Ramadas; Josalyn L Cho; Khristianna Jones; Ana Pardo-Saganta; Jayaraj Rajagopal; Ramnik J Xavier; Benjamin D Medoff
Journal:  J Immunol       Date:  2015-06-03       Impact factor: 5.422

Review 3.  Mechanisms how mucosal innate immunity affects progression of allergic airway disease.

Authors:  Allan R Brasier
Journal:  Expert Rev Respir Med       Date:  2019-02-13       Impact factor: 3.772

4.  Ribosomal protein S3 gene silencing protects against experimental allergic asthma.

Authors:  Jinrui Dong; Wupeng Liao; Hong Yong Peh; Tze Khee Chan; W S Daniel Tan; Li Li; Amy Yong; W S Fred Wong
Journal:  Br J Pharmacol       Date:  2017-02-24       Impact factor: 8.739

5.  Dysregulation of the glutaredoxin/S-glutathionylation redox axis in lung diseases.

Authors:  Shi B Chia; Evan A Elko; Reem Aboushousha; Allison M Manuel; Cheryl van de Wetering; Joseph E Druso; Jos van der Velden; David J Seward; Vikas Anathy; Charles G Irvin; Ying-Wai Lam; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-06       Impact factor: 4.249

6.  Overview on Interactive Role of Inflammation, Reactive Oxygen Species, and Calcium Signaling in Asthma, COPD, and Pulmonary Hypertension.

Authors:  Lillian Truong; Yun-Min Zheng; Sharath Kandhi; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Central Role of the NF-κB Pathway in the Scgb1a1-Expressing Epithelium in Mediating Respiratory Syncytial Virus-Induced Airway Inflammation.

Authors:  Bing Tian; Jun Yang; Yingxin Zhao; Teodora Ivanciuc; Hong Sun; Maki Wakamiya; Roberto P Garofalo; Allan R Brasier
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

8.  Effect of a chemical chaperone, tauroursodeoxycholic acid, on HDM-induced allergic airway disease.

Authors:  Jalahalli M Siddesha; Emily M Nakada; Bethany R Mihavics; Sidra M Hoffman; Gurkiranjit K Rattu; Nicolas Chamberlain; Jonathon M Cahoon; Karolyn G Lahue; Nirav Daphtary; Minara Aliyeva; David G Chapman; Dhimant H Desai; Matthew E Poynter; Vikas Anathy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-06       Impact factor: 5.464

Review 9.  Animal models of allergic airways disease: where are we and where to next?

Authors:  David G Chapman; Jane E Tully; James D Nolin; Yvonne M Janssen-Heininger; Charles G Irvin
Journal:  J Cell Biochem       Date:  2014-12       Impact factor: 4.429

10.  Propofol Attenuates Airway Inflammation in a Mast Cell-Dependent Mouse Model of Allergic Asthma by Inhibiting the Toll-like Receptor 4/Reactive Oxygen Species/Nuclear Factor κB Signaling Pathway.

Authors:  Hong-Yi Li; Jing-Xia Meng; Zhen Liu; Xiao-Wen Liu; Yu-Guang Huang; Jing Zhao
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.